Vaccine will be available for people aged 60 and above

Views 4.6K

In an Australian first, a vaccine for respiratory syncytial virus or RSV has been approved by the therapeutic goods administration and will soon be available for those aged 60 and above. The vaccine is a protein-based immunisation to help prevent lower respiratory tract disease caused by RSV, which can be fatal.

Share This Video


Download

  
Report form